Gene: SOCS7
Official Full Name: suppressor of cytokine signaling 7provided by HGNC
Gene Summary: Predicted to enable phosphorylation-dependent protein binding activity; signaling adaptor activity; and ubiquitin-like ligase-substrate adaptor activity. Predicted to be involved in insulin receptor signaling pathway; proteasome-mediated ubiquitin-dependent protein catabolic process; and regulation of neuron migration. Predicted to act upstream of or within brain development; fat cell differentiation; and protein ubiquitination. Located in cytosol. Is active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11166 | SOCS7 Knockout cell line (HeLa) | Human | SOCS7 | 1:3~1:6 | Negative | Online Inquiry |
KO11167 | SOCS7 Knockout cell line (HCT 116) | Human | SOCS7 | 1:2~1:4 | Negative | Online Inquiry |
KO11168 | SOCS7 Knockout cell line (HEK293) | Human | SOCS7 | 1:3~1:6 | Negative | Online Inquiry |
KO11169 | SOCS7 Knockout cell line (A549) | Human | SOCS7 | 1:3~1:4 | Negative | Online Inquiry |
SOCS7 Gene Knockout Cell Lines represent a groundbreaking tool in genetic research, specifically designed to investigate the role of the Suppressor of Cytokine Signaling 7 (SOCS7) protein in various biological processes. These cell lines have been genetically modified to disrupt the expression of SOCS7, enabling researchers to elucidate the gene’s function in signal transduction pathways related to immune response, cellular differentiation, and metabolism.
The primary function of SOCS7 is to modulate intracellular signaling by inhibiting the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway, which is pivotal in responding to cytokines and growth factors. By utilizing SOCS7 knockout cell lines, scientists can observe alterations in cellular behavior, cytokine signaling, and associated phenotypes that arise from the absence of this regulatory protein. This mechanism provides a robust framework for studying the implications of SOCS7 dysregulation in pathologies such as cancer, autoimmune diseases, and metabolic disorders.
The scientific importance of SOCS7 Gene Knockout Cell Lines extends to research applications across various fields, including immunology, oncology, and metabolism studies. In clinical settings, these models can be invaluable for understanding disease mechanisms and identifying novel therapeutic targets. Compared to other gene knockout technologies, these cell lines offer the advantage of a well-characterized genetic background and the ability to accurately mimic in vivo conditions, leading to more reliable results.
This product stands out due to its specificity for SOCS7 and the efficiency of its production methods, which ensure high-quality cell lines that meet the rigorous demands of modern research. For researchers and clinicians alike, the SOCS7 Gene Knockout Cell Lines open new avenues for investigation, leading to potential breakthroughs in understanding disease pathology and treatment.
Our company specializes in the development and provision of advanced biological products, leveraging extensive expertise in genetic engineering to deliver tools that empower research and innovation. With our commitment to quality and customer support, we ensure that our products meet the highest standards, enabling scientific advancement in diverse fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.